When injection site reactions significantly impact treatment adherence, discussing alternative GLP-1 options with healthcare providers represents a reasonable approach, as therapeutic efficacy across the class often allows successful substitution while maintaining glycemic control or weight management benefits
As pharmaceutical innovation increasingly converges around metabolic health, neuroscience and advanced delivery technologies, strategic flexibility could become an increasingly valuable differentiator for emerging biotechnology companies
Contraindications include active malignancy, uncontrolled diabetes, pregnancy, or history of certain cancers
That depends on the medication, your response, and your treatment plan
Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index 27 kg/m 2: surmount-1 ambulatory blood pressure monitoring substudy